Poseida Therapeutics

Poseida Therapeutics is a company listed under the stock ticker PSTX (US).

View the org chart displaying its 26 main executives

Most searched biographies at Poseida Therapeutics

• Kristin Yarema, President and Chief Executive Officer
• John Schmid, Director
• Mark Gergen, Executive Chairman of the Board

Popular executive movements at Poseida Therapeutics

• Syed Rizvi has joined the company as Chief Medical Officer  (posted on March 26 2024).
• Kristin Yarema who is President, Cell Therapy, will be promoted to President and Chief Executive Officer on Jan. 1, 2024  (posted on October 10 2023).

Create your alert
to follow the executive moves at Poseida Therapeutics.

Poseida Therapeutics has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Poseida Therapeutics

Social media about Poseida Therapeutics

• Poseida Therapeutics on Wikipedia, Google News & Yahoo Finance
• Poseida Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Kristin Yarema

Call Poseida Therapeutics at +1 858...

View the org chart

Register to receive your alert

Report an error